Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers T > Headlines for T2 Biosystems, Inc. > News item |
T2 Biosystems plans to price initial public offering of common stock
Goldman Sachs and Morgan Stanley to be bookrunning managers
By Devika Patel
Knoxville, Tenn., July 2 – T2 Biosystems, Inc. will conduct an initial public sale of its common stock with a greenshoe option, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.
Goldman, Sachs & Co. and Morgan Stanley are the joint bookrunning managers. Leerink Partners and Janney Montgomery Scott are the co-managers.
Proceeds will be used for research and development, marketing and commercialization of product candidates and general corporate purposes.
The in-vitro diagnostics company is based in Lexington, Mass. The company intends to list its common stock on the Nasdaq under the symbol “TTOO.”
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.